Anxiety disorders are among the most common mental health conditions in the United States. For many patients, standard treatments such as therapy, SSRIs, SNRIs, and other medication strategies can make a meaningful difference. For others, anxiety remains disruptive despite serious effort and appropriate care.
At KDI Health in Frisco, TX, we offer ketamine therapy as an off-label, physician-supervised option for carefully selected patients whose anxiety has not responded adequately to conventional treatment. We do not present ketamine as a first-line anxiety treatment or a guaranteed solution. We present it as a clinical conversation for patients who need another carefully monitored option.
Understanding what the evidence says — and what it does not yet say — is the foundation of that conversation.
Anxiety Is Not One Single Condition
Anxiety is a broad clinical category. It can include generalized anxiety disorder, social anxiety disorder, panic disorder, specific phobias, and other patterns of persistent fear, worry, avoidance, or physical alarm.
That distinction matters because two patients may both say, “I have anxiety,” while describing very different experiences. One person may live with constant worry and muscle tension. Another may avoid social situations because of fear of judgment. Another may experience sudden panic attacks that feel physically dangerous. Another may have anxiety that is closely tied to depression, PTSD, chronic pain, or medical stress.
At KDI Health, we do not treat anxiety as a generic label. We want to understand the pattern, the history, the triggers, the prior treatments, the medications, and what the patient is hoping treatment will change.
Patients can learn more about our condition-specific approach on our anxiety treatment in Frisco, TX page.
When First-Line Anxiety Treatment Is Not Enough
First-line anxiety care often includes psychotherapy, medication, or both. Cognitive behavioral therapy, exposure-based therapy, SSRIs, SNRIs, and other evidence-based strategies help many patients. We respect those treatments and often encourage patients to continue appropriate care with their existing therapist, psychiatrist, or prescribing provider.
But “effective” does not mean effective for everyone.
Some patients try multiple medications and experience only partial relief. Some have side effects that make a medication difficult to continue. Some benefit from therapy but still feel trapped in physical panic, rumination, avoidance, insomnia, or a nervous system that will not settle. Some patients have anxiety and depression together, which can make treatment planning more complicated.
Those are the patients who may begin asking whether ketamine belongs in the conversation.
For patients whose anxiety overlaps with depression, our article on IV ketamine for treatment-resistant depression may also be useful because much of the ketamine evidence base is strongest in mood-disorder research.
What We Know About Ketamine and Anxiety
Ketamine’s use for anxiety disorders is off-label. It is not FDA-approved for generalized anxiety disorder, social anxiety disorder, panic disorder, phobias, or other anxiety diagnoses.
That clarity is important.
Research on ketamine for anxiety is growing, but it is not as extensive as the evidence base for ketamine in treatment-resistant depression. Some studies and reviews suggest ketamine may reduce anxiety symptoms in selected patients, including those with treatment-resistant anxiety or anxiety symptoms that occur alongside depression. At the same time, researchers continue to study which anxiety subtypes may respond best, how long benefits may last, how maintenance should be handled, and which patients may not be appropriate candidates.
At KDI Health, we do not want patients to hear “promising evidence” and translate that into “this will definitely work for me.” Anxiety care should be individualized, and ketamine should be considered only after a careful review of the full clinical picture.
Why Ketamine Works Differently From Daily Anxiety Medication
Many common anxiety medications affect serotonin, norepinephrine, GABA, or related systems. They are usually taken daily and may take weeks to show their full effect.
Ketamine works differently. It acts primarily through NMDA receptor antagonism and the glutamate system, which is involved in learning, memory, mood regulation, and neuroplasticity. In practical terms, researchers are interested in whether ketamine may create a temporary window of increased flexibility in brain circuits that have become stuck in patterns of threat, fear, avoidance, or depressive thinking.
That does not mean ketamine “rewires the brain” in a simple or permanent way. It also does not mean ketamine replaces therapy. For some patients, symptom relief may create a window where therapy, behavioral change, or daily coping skills feel more accessible. But that window still needs a plan.
Our ketamine for anxiety in Frisco TX overview explores how this approach has helped patients in the DFW area take a meaningful step forward in care.
Why the Treatment Setting Matters for Anxiety Patients
For anxiety patients, the treatment environment is not a small detail. It can shape the entire experience.
At KDI Health, intravenous ketamine treatment is administered in a supervised clinical setting. Before treatment begins, we review the patient’s medical history, psychiatric history, current medications, prior treatment response, and safety considerations. During treatment, patients are monitored as the acute effects of ketamine unfold.
This matters because ketamine can produce dissociation, altered perception, changes in time awareness, emotional intensity, dizziness, nausea, or a feeling of detachment from the body. For someone with anxiety, especially panic or fear of losing control, that description can sound intimidating.
We address that directly before treatment begins. Patients deserve to know what the experience may feel like, what monitoring looks like, how long the acute effects usually last, and what support is available during the session.
Anxiety About the Infusion Itself Is Common
Many anxiety patients are not only asking, “Will ketamine help my anxiety?” They are also asking, “What if the treatment makes me panic?”
That is a reasonable concern.
Some patients may experience temporary anxiety or discomfort during the dissociative phase of treatment. Others are surprised that the experience feels more manageable than they expected, especially when they have been prepared carefully and know they are being monitored. The goal is not to dismiss the fear. The goal is to plan for it.
We talk through what patients may feel during the session, how to prepare, what to do if anxiety rises, and why medical supervision matters. For some patients, that preparation is enough to proceed with more confidence. For others, ketamine may not be the right fit, or the timing may not be right.
The decision should be clinical, not rushed. Reviewing our ketamine therapy FAQs can help patients arrive at their consultation with a clearer understanding of the process.
How Dr. Gasper Approaches Patient Selection
At KDI Health, ketamine therapy begins with evaluation. Dr. Stephen Gasper’s background as a board-certified emergency physician informs the way we think about monitoring, risk, and patient safety. Patients can learn more about his background on our About KDI Health page.
Before recommending ketamine for anxiety, we want to understand the patient’s diagnosis, symptom pattern, medical history, psychiatric history, substance use history, current medications, cardiovascular status, and prior response to treatment. We also want to understand what other providers are involved and whether ketamine would fit into a broader care plan.
Certain medication combinations, medical conditions, psychiatric histories, or safety concerns may require additional discussion or may make ketamine inappropriate. Patients should not stop or change prescribed medications in order to pursue ketamine without guidance from the providers who manage those medications.
Good anxiety care is not just about offering another intervention. It is about knowing when an intervention is appropriate.
Ketamine Works Best as Part of a Broader Plan
Ketamine therapy should not be treated as a stand-alone answer for anxiety.
For many patients, the strongest plan includes continued psychotherapy, psychiatric care, medication management when appropriate, sleep support, lifestyle changes, and practical work on avoidance patterns. If ketamine reduces symptom intensity for a period of time, that may create an opportunity to build healthier patterns. But the treatment series itself is only one part of the process.
This is especially important for patients whose anxiety has narrowed their lives over time. Relief from symptoms matters, but so does what the patient is able to do with that relief: return to therapy, re-engage with relationships, tolerate uncertainty, improve sleep, reduce avoidance, or take steps toward normal routines.
We encourage patients to think about ketamine as a possible part of care, not the entire plan. The benefits of ketamine infusion therapy for anxiety treatment in Frisco, TX are best realized within this kind of comprehensive, ongoing approach.
Cost, Logistics, and Practical Questions
Patients often have practical questions before they feel ready to schedule a consultation.
They want to know how treatment fits into work, transportation, family responsibilities, medications, and cost. Those questions are not secondary. They are part of whether treatment is realistic.
Ketamine therapy for anxiety is typically not covered by standard commercial health insurance because it is an off-label psychiatric use. Patients who have concerns about cost can ask our team about financing options and practical planning before making a treatment decision.
Patients should also plan for transportation after treatment. Ketamine can temporarily affect perception, coordination, and alertness, so patients should not drive themselves home after a session.
When to Consider a Consultation
A consultation may be appropriate if anxiety continues to interfere with your life despite standard treatment, if you have tried multiple evidence-based approaches without adequate relief, or if anxiety occurs alongside depression, trauma symptoms, or another condition that has made treatment more complicated.
A consultation does not obligate you to begin treatment. It is a chance to ask whether ketamine is medically appropriate, what the risks and benefits may be, what expectations are realistic, and how treatment would fit into your broader care.
If you are dealing with anxiety in Frisco or the broader DFW area and want to understand whether ketamine therapy may be appropriate, you can contact KDI Health to schedule a consultation.
Frequently Asked Questions
Is ketamine approved by the FDA for anxiety treatment?
No. Ketamine therapy for anxiety disorders is off-label. It is not FDA-approved for generalized anxiety disorder, social anxiety disorder, panic disorder, phobias, or other anxiety diagnoses. Research is ongoing, and a physician evaluation is necessary to determine whether off-label ketamine may be appropriate for a specific patient.
How does ketamine for anxiety differ from typical anxiety medications?
Many standard anxiety medications are taken daily and work through serotonin, norepinephrine, GABA, or related systems. Ketamine is administered in a clinical setting and acts primarily through the glutamate/NMDA system. It may produce effects more rapidly for some patients, but results vary and the treatment is not a substitute for comprehensive anxiety care.
Can I continue my current anxiety medications while receiving ketamine therapy?
That depends on your medication regimen, medical history, and psychiatric history. Some medications may be continued, while others require careful review. Do not stop, start, or change prescribed medications without speaking with the providers who manage them.
Will the ketamine infusion make my anxiety worse during the session?
Some patients may experience temporary anxiety or discomfort during the dissociative phase of treatment. Others tolerate the experience better than they expected after careful preparation. We discuss this risk before treatment begins and monitor patients during the session. If anxiety sensitivity is a major concern, it should be part of the consultation conversation.
How quickly can I expect to see results from ketamine therapy for anxiety?
Some patients notice changes within hours or days, while others experience more gradual improvement across a treatment series. Some patients may not respond adequately. The timeline varies by individual, anxiety subtype, co-occurring conditions, medications, and treatment history.
Is ketamine right for every patient with anxiety?
No. Ketamine is not right for every patient with anxiety. Medical history, psychiatric history, medication interactions, substance use concerns, cardiovascular factors, and the patient’s current stability all matter. A consultation is the appropriate place to review candidacy.
Key Takeaways
- Anxiety disorders are common, but they are not all the same condition.
- First-line care such as psychotherapy and medication helps many patients, but some continue to have significant symptoms.
- Ketamine therapy for anxiety is off-label and not FDA-approved for anxiety disorders.
- The evidence for anxiety is promising but less extensive than the evidence for treatment-resistant depression.
- A supervised clinical environment matters because ketamine can produce dissociation, altered perception, and temporary anxiety or discomfort.
- At KDI Health in Frisco, TX, ketamine candidacy is evaluated through a physician-led review of the patient’s full clinical picture.
Conclusion
Anxiety that has not responded to conventional treatment is not a character flaw. It is a clinical problem that deserves a careful clinical conversation.
At KDI Health in Frisco, TX, we approach anxiety with honesty, caution, and respect for what patients have already tried. Ketamine therapy may be appropriate for some patients with treatment-resistant anxiety, especially when anxiety overlaps with depression or other difficult-to-treat symptoms. It is not right for everyone, and it should not be considered without proper screening and supervision.
The next step is simply a conversation: what you are experiencing, what has not worked, and whether ketamine therapy may belong in your care plan.
About Dr. Stephen Gasper
Dr. Stephen Gasper is the owner and medical director of KDI Health Ketamine Clinic, which he founded in early 2021 in Frisco, TX. At the age of 17, he enlisted in the Marines, serving four years as a forward observer in the infantry. He then moved to Texas and obtained his BS in Biology from the University of Dallas.
Dr. Gasper received his Medical Degree from UTHealth Houston in 2011 and practiced medicine in the DFW area for more than 10 years as a board-certified emergency physician. He was inspired to found KDI Health during the COVID pandemic because of the effectiveness of ketamine as a therapy adjunct for veterans and the broader community struggling with depression, anxiety, and PTSD.
At KDI Health, Dr. Gasper provides direct physician involvement throughout the ketamine care process.
Medical Disclaimer
The information provided in this blog is for educational purposes only and does not constitute medical advice. Treatment outcomes vary by individual. Please consult with a qualified healthcare provider before beginning any new treatment. Discuss with your provider whether ketamine therapy is appropriate for your specific medical and mental health history. If you are in immediate danger or may harm yourself, call 911, call or text 988, or go to the nearest emergency room.
Works Cited
Banov, M. D., Young, J. R., Dunn, T., & Szabo, S. T. (2020). Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: A review of the literature. CNS Spectrums, 25(3), 331–342.
Glue, P., Neehoff, S. M., Sabadel, A., Broughton, L., Le Nedelec, M., Shadli, S., McNaughton, N., & Medlicott, N. J. (2020). Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders. Journal of Psychopharmacology, 34(3), 267–272.
National Institute of Mental Health. (2024). Anxiety disorders. U.S. Department of Health and Human Services, National Institutes of Health.
National Institute of Mental Health. (2024). Any anxiety disorder. U.S. Department of Health and Human Services, National Institutes of Health.
Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., Schatzberg, A. F., Summergrad, P., & Nemeroff, C. B. (2017). A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry, 74(4), 399–405.
Taylor, J. H., Landeros-Weisenberger, A., Coughlin, C., Mulqueen, J., Johnson, J. A., Gabriel, D., Reed, M. O., Jakubovski, E., Bloch, M. H., & Pittenger, C. (2018). Ketamine for social anxiety disorder: A randomized, placebo-controlled crossover trial. Neuropsychopharmacology, 43(2), 325–333.
Tully, J. L., Dahlén, A. D., Haggarty, C. J., Schiöth, H. B., & Brooks, S. J. (2022). Ketamine treatment for refractory anxiety: A systematic review. British Journal of Clinical Pharmacology, 88(10), 4412–4426.
